ºÐÀÚÇ¥ÀûÄ¡·á(MTT) ½ÃÀåÁ¶»çº¸°í¼­

ºÐÀÚÇ¥ÀûÄ¡·á(MTT) ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå±Ô¸ð, »ê¾÷ºÐ¼®, ÇâÈÄ ½ÃÀå¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.

1 - 25 (Àüü: 255°Ç)
¼¼°èÀÇ ¸®Åö½Ã¸¿ ½ÃÀå
Rituximab
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,186,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Áø´Ü¿ë Ư¼ö Ç×ü ½ÃÀå
Diagnostic Specialty Antibodies
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,186,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ç¥Àû ´Ü¹éÁú ºÐÇØ ½ÃÀå : À¯Çüº°, ÀûÀÀÁõº°, Á¦Çüº°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(-2035³â)
Targeted Protein Degradation Market by Type [PROTACs (Vepdegestrant, Bavdegalutamide), SERDs (Elacestrant), Molecular Glues (Mezigdomide), LDD, LYTAC/ATAC], Indication (Oncology, Inflammatory), Formulation (Oral), End User - Global Forecast to 2035
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 4,950 £Ü 6,927,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ç¥Àû Ä¡·áÁ¦ ½ÃÀå
Targeted Therapeutics
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,186,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÌÁß Æ¯À̼º Ç×ü ½ÃÀå
Bispecific Antibodies
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,186,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ç×ü ÀýÆí ½ÃÀå
Antibody Fragments
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,186,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ç×ü¾à¹°Á¢ÇÕü(ADC) ¼öŹ Á¦Á¶ ½ÃÀå
Antibody Drug Conjugates Contract Manufacturing
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,186,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÆÄ±¹¼º Ç×ÀÎÁöÁú ÁõÈıº ½ÃÀå
Catastrophic Antiphospholipid Syndrome
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,186,000 (ºÎ°¡¼¼ º°µµ)
ºÐÀÚ¼¼Æ÷À¯ÀüÇÐ ½ÃÀå º¸°í¼­ : Á¦Ç° À¯Çü, ±â¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)
Molecular Cytogenetics Market Report by Product Type, Technology (Comparative Genomic Hybridization, Fluorescence in SITU Hybridization, Immunohistochemistry, Karyotyping, and Others), Application, End User, and Region 2025-2033
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 2,999 £Ü 4,196,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÌÁ߯¯À̼ºÇ×ü ¾à¹° º¹ÇÕü ½ÃÀå : ÀÓ»ó½ÃÇè, °³¹ß Ç÷§Æû, °æÀï ±¸µµ¿Í ½ÃÀå ±âȸ(2025³â)
Global Bispecific Antibody Drug Conjugates Clinical Trials, Development Platforms, Competitive Landscape & Market Opportunity Insight 2025
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,300 £Ü 4,618,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾Ï Ç×ü¾à¹°Á¢ÇÕü(ADC) ½ÃÀå : ½ÃÀå ±âȸ, ƯÇã, °¡°Ý, ½ÂÀÎ ÀǾàǰ ÆÇ¸Å ¹× ÀÓ»ó½ÃÇè µ¿Çâ(2031³â)
Global Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2031
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 4,200 £Ü 5,877,000 (ºÎ°¡¼¼ º°µµ)
´ÜŬ·ÐÇ×ü Ä¡·áÁ¦ ½ÃÀå : °ø±Þ¿øº°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°
Monoclonal Antibody Therapeutics Market, By Source, by Application, By Distribution Channel, and By Region
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,500 £Ü 6,297,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾ÐŸ¸Ó ½ÃÀå - »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø : À¯Çüº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Aptamers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Type, By Technology, By Application, By End user, By Region & Competition, 2020-2030F
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,500 £Ü 6,297,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ç¥Àû ´Ü¹éÁú ºÐÇØ ½ÃÀå
Targeted Protein Degradation
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,850 £Ü 8,186,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ÙŬ·ÐÇ×ü ½ÃÀå
Polyclonal Antibodies
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,850 £Ü 8,186,000 (ºÎ°¡¼¼ º°µµ)
ºÐÀÚ¼¼Æ÷ À¯ÀüÇÐ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¿ëµµº°, ±â¼úº°, Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2033³â)
Molecular Cytogenetics Market Size, Share & Trends Analysis Report By Application, By Technology, By Product, By End Use, By Region, And Segment Forecasts, 2025 - 2033
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,950 £Ü 8,326,000 (ºÎ°¡¼¼ º°µµ)
Ç×ü¾à¹°Á¢ÇÕü(ADC) À§Å¹»ý»ê ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
Antibody Drug Conjugates Contract Manufacturing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,995 £Ü 6,990,000 (ºÎ°¡¼¼ º°µµ)
¹Ì±¹ÀÇ Ç×ü¾à¹°Á¢ÇÕü(ADC) ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¿ëµµº°, ±â¼úº°, Á¦Ç°º°, Ÿ°Ùº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
U.S. Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Breast Cancer, Urothelial Cancer & Bladder Cancer), By Technology, By Product, By Target, And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,950 £Ü 8,326,000 (ºÎ°¡¼¼ º°µµ)
È޹̶ó(Humira) ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø : Á¦Ç°º°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Humira Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Distribution Channel, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,500 £Ü 6,297,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ºÐÀÚ¼¼Æ÷À¯ÀüÇÐ ½ÃÀå
Molecular Cytogenetics
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,850 £Ü 8,186,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ç×ü ½ÃÀå(2025-2029³â)
Global Antibody Market 2025-2029
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 2,500 £Ü 3,498,000 (ºÎ°¡¼¼ º°µµ)
ŰƮ·ç´Ù(Keytruda) ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, ÁöºÒÀÚº°, À¯Åë ä³Îº°, ¿ëµµº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2025-2032³â)
Keytruda Market Size, Share, and Growth Analysis, By Payer (Commercial/Private, Public), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy), By Application, By Region - Industry Forecast 2025-2032
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 5,300 £Ü 7,416,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÁßÈ­ Ç×ü ½ÃÀå º¸°í¼­(2025³â)
Neutralizing Antibody Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,283,000 (ºÎ°¡¼¼ º°µµ)
¸ð³ëŬ·Î³Î Ç×ü ½ÃÀå : °ø±Þ¿ø À¯Çüº°, »ý»ê À¯Çüº°, ÀûÀÀÁõº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - ¼¼°è »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2025-2032³â)
Monoclonal Antibody Market, By Source Type, By Production Types, By Indication, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 3,250 £Ü 4,548,000 (ºÎ°¡¼¼ º°µµ)
´ÜÀÏŬ·ÐÇ×ü ½ÃÀå : ¿¹Ãø(2025-2030³â)
Monoclonal Antibodies Market - Forecasts from 2025 to 2030
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 3,950 £Ü 5,527,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.